Ferumoxytol-enhanced MRI for vein problems
Treatments studied
Part of Heart & circulation clinical trials.
This trial uses a special iron-based contrast agent called ferumoxytol during an MRI scan to get clearer pictures of your veins. It's for people who may have vein blockages or other vein issues that need better imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You have a suspected or confirmed vein problem (like in your legs or central veins) that needs this type of MRI.
- You are willing and able to sign a consent form.
- You are not allergic to iron or dextran, and you have not had a bad reaction to IV iron before.
- You are not pregnant.
- You do not have iron overload conditions like hemochromatosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special iron-based contrast agent called ferumoxytol can improve MRI images of arteries affected by atherosclerosis. It may help doctors see blockages or inflammation more clearly.
This trial tests a new type of MRI with a special dye (ferumoxytol) to better find blood clots in the heart. It is for people who have a left ventricular aneurysm (a bulging area in the heart's main pumping chamber) or who had a heart procedure called percutaneous ventricular reconstruction about 6 months ago.
This trial tests a special MRI using a contrast agent called ferumoxytol to better see calcium buildup in heart arteries. It may help people who need a coronary angiogram and have some calcium visible on a prior CT scan.
This study uses special MRI scans to measure blood flow in the veins of the lungs in babies, aiming to help doctors better understand and treat conditions like chronic lung disease or abnormal vein connections.
This study tests whether a special MRI contrast agent (Ferumoxytol) can improve brain imaging in healthy people and people with temporal lobe epilepsy. It may help doctors see more detail in the brain.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
Hear when a new Venous Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.